Archive for July, 2010

U.S. Passport Fees to Increase on July 13th

Thursday, July 8th, 2010 by

Fees for U.S. Passports increase substantially in less than a week.  Currently, adult fees for the standard Passport Book are $100 for a new one and $75 for renewals.  These fees rise to $135 and $110, respectively.  For children the increases are also large.  Current fees are $85 for new passports or renewals; this will go up to $105.

Some other fees are also going up or are being charged for the first time – additional pages for your book used to be free but are now $82, and the file search fee has gone up from $60 to $150.  The file search is required when an applicant is unable to present proof of citizenship.

All of the details can be found at the U.S. Department of State’s web site – new fees and current rates.

We put together a simple chart to highlight the changes (see below). 

The State Department’s main page for passports can answer all of your questions about passports – when you need one, how to get one fast, what to do when you lose one, etc.  Get prepared for your next fun, international trip and save some money by doing it this week!

Share

H1N1 (Swine) Flu: Should we still be concerned?

Thursday, July 8th, 2010 by

A recent article  in the Washington Post detailing criticism of the World Health Organization’s handling of the H1N1 (swine) flu pandemic, suggests that “much ado was made about nothing” and that the WHO was unduly influenced by drug manufacturers who stood to gain from widespread panic over the spread of the novel H1N1 virus.

Yet in a separate, sparsely circulated news article released last week, India reported that the number of swine flu cases jumped dramatically in June.  During the week of June 8-14, the country recorded 168 H1N1 cases with 14 deaths.  In comparison, from June 21-27, there were 345 new cases of H1N1 flu with 17 deaths. Somewhat alarmingly, the virus appeared in parts of India that were minimally affected last year. 

The news from India came at a time when over 25% of the H1N1 vaccine produced last year for the United States, a staggering 40 million doses worth over $250 million, was destroyed because it had expired.  An additional 30 million doses will likely also expire without being used.  If added to the 40 million doses slated for destruction this week, it means that almost half of the vaccine produced for the U.S. will have gone to waste. 

Despite unprecedented publicity by the World Health Organization, and an international campaign to encourage immunization against the novel H1N1 virus, a vast number of people remain unimmunized against H1N1.  Should we be concerned?  If the recent news out of India is any indication, H1N1 has not gone away and may become front page news once again in the coming flu season, typically late November thru March.

Scientists cognizant of the Spanish flu timeline from early 1918 until 1920, during which time three separate strains of the influenza virus emerged – with the second being the most deadly – are quick to point out that the novel H1N1 virus from last year could easily mutate and cause widespread devastation in an unimmunized population. Should this occur, the waste of millions of unused vaccine, and the consequential reluctance of manufacturers to mass produce any more doses, could have catastrophic consequences in the months ahead.

Travelers should keep in mind that it is flu season in many parts of the world, and that those travelling to the Southern hemisphere in particular should pay close attention to regions reporting increased H1N1 activity.  Ask your physician about obtaining the H1N1 vaccine, particularly if you are pregnant or have a chronic illness such as asthma or HIV/AIDs.  Criticism of the World Health Organization notwithstanding, it is still premature and historically unjustifiable to write off the novel H1N1 pandemic as a fabrication for the benefit of vaccine manufacturers.

Photo by Jeremy Brooks

Share

Dengue Fever in the United States

Wednesday, July 7th, 2010 by

Last month we addressed dengue fever’s reappearance in the United States.  Since last summer 28 cases have been reported.  Though this disease is a little known entity in the United States, it is the most common vector-borne viral disease in the world, causing an estimated 50–100 million infections and 25,000 deaths each year.  Dengue is now the leading cause of acute febrile illness in U.S. travelers returning from the Caribbean, South America, and Asia.  However, those who have not travelled abroad or do not reside close to the Mexican border have historically not been at risk.

Dengue fever often exhibits only mild symptoms, so there is an excellent chance that hundreds of other infections have gone undetected.  The virus is transmitted primarily by the Ae. Aegypti mosquito, and results in fever, chills, headache, muscle aches, nausea with vomiting, eye pain, and occasionally a spotty red rash on the trunk or legs.  The disease may be suspected when there is a drop in the body’s platelet count- the small cells responsible for blood clotting, but can only be confirmed with the detection of antibodies in the blood. There is no treatment for dengue fever, and symptoms will usually resolve spontaneously within days.  However, in a small percentage of cases, the disease may progress to cause internal bleeding with organ failure and death. 

A vaccine for dengue fever is in development, and may ultimately join vaccines for hepatitis and yellow fever as recommended inoculations for U.S. citizens travelling to tropical areas.  In the meantime, visitors returning from areas where dengue is endemic should be suspicious of possible dengue infection if experiencing flu like symptoms, and seek medical attention if a spotty red rash develops.

Photo by Koala:Bear

Share